Adverse Event Ontology (OAE) Development Team
The Adverse Event Ontology (OAE) Core Development Team currently includes the following members:
- Yongqun "Oliver" He, DVM, PhD, Associate Professor, University of Michigan Medical School, Ann Arbor, MI, USA
Vaccine adverse event domain expert, and the primary developer of the early versions of OAE.
- Allen Xiang, MS, Software developer and bioinformatician, University of Michigan Medical School
OAE software developer and manager - Sirarat Sarntivijai, PhD candidate (major: bioinformatics), University of Michigan Medical School
Influenza vaccine adverse event modeling - Abra Guo, Undergraduate student (major: neuroscience), University of Michigan
Analysis of neuropathy adverse events induced by chemotherapy drugs - Luca Toldo, PhD, Principal Scientist, Knowledge Management, Merck KGaA, Darmstadt, Germany
Adverse drug event (ADE) literature mining - Harsha Gurulingappa, Bonn-Aachen International Center for Information Technology [B-IT] Research School, University of Bonn, Bonn, Germany; Fraunhofer Institute for Algorithms and Scientific Computing [SCAI], Schloss Birlinghoven, Sankt Augustin, Germany
ADE modeling - Richard D. Boyce, PhD,
Assistant Professor, Department of Biomedical Informatics, University of Pittsburgh
ADE causality analysis - Barry Smith, PhD, Professor, University at Buffalo
OAE development aligned with BFO and OGMS
The following researchers contribute to discussions in the OAE mailing list:
- Melanie Courtot, University of British Columbia and BC Cancer Research Centre (BCCRC), Vancouver, Canada
- Ryan Brinkman, PhD, University of British Columbia and BC Cancer Research Centre (BCCRC), Vancouver, Canada
- Alan Ruttenberg, Director Clinical and Translational Data Exchange at University at Buffalo, and Science Commons.
Join the OAE Development Team: Membership in the Adverse Event Ontology Development Team is determined only by participation. We welcome the participation of new members. To join, let us know of your interest by emailing Oliver He.
